← All stories
Markets
Hikma Pharmaceuticals (LSE:HIK): Why Is Ohio Suddenly Central to Its Growth Plan?
Highlights Fresh capital is being committed to expand manufacturing sites in Columbus and Bedford, Ohio. The build-out spans injectable, oral solid dose and nasal inhalation capability, adding skilled roles. A share repurchase programme has…
Covered by 1 outlet
All coverage · 1 article